At the end of 1954, Dr. Robert Cutter, president of Cutter Laboratories of Berkeley, Calif., wrote in his annual report to stockholders: "We are up to our ears in the Salk poliomyelitis vaccine production. Around the middle of the year you are either going to look on this decision as being very dumb or very smart, depending on how the poliomyelitis vaccine turns out." Last week, as a result of the Salk vaccine, the company was up to its ears in the most unfavorable corporation publicity in recent years. More and more medical men were asking for a...
To continue reading:
or
Log-In
